MLP & Strategic Equity Fund (MTP) a Sell on Adverse Earnings Growth

The current recommendation of Sell for MLP & Strategic Equity Fund (NASDAQ:MTP) is the result of using the system for investing of Louis Navellier and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking MTP has had from Portfolio Grader for 2 months.

MTP is one of the 783 companies in the GICS Health Care sector and is a component of the 344 company Biotechnology GICS industry group within this sector. The market value of MTP is $35.1 billion which falls in the top 10% of its industry group The ranking for MTP by Portfolio Grader places it 255 among the 344 companies in this industry group, giving it a lower than average position.

The Health Care sector is ranked number 10 among the 12 sectors in the Portfolio Grader universe putting it in the bottom quartile of all the GICS sectors. The Biotechnology industry group is ranked 58 among the 69 industry groups within the GICS sectors, placing it well below-average in terms of the Navellier scoring system.

The scores realized by MTP are average or below-average scores in 8 of the 8 fundamental metrics used by Portfolio Grader in the ranking of company stocks.

MTP's operational scores are below the industry norms for sales growth, operating margin, and earnings growth. Scores for visibility of earnings are worse than the industry norms for earnings revisions, earnings surprises, and earnings momentum. MTP's scores for cash flow and return on equity are worse than its industry group average. These fundamental scores give MLP & Strategic Equity Fund a position in the top quartile of the industry group.

Quantitatively, Portfolio Grader uses the Navellier Proprietary Quantitative Score to measure MTP's shares from the aspect of risk/reward. This unique scoring approach weighs the relative value of the company's shares based on the current price of the shares relative to its peers, the market and risk associated with its industry and sector groups. Using this risk/reward calculation, MTP currently scores well below-average in its industry group compared to its peers.

Louis Navellier's proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results, with A being 'strong buy' and F being 'strong sell'. Explore the tool here.

Commentary provided by UpTick Data Technologies.


Article printed from InvestorPlace Media, https://investorplace.com/2017/10/mlp-strategic-equity-fund-mtp-a-sell-on-adverse-earnings-growth/.

©2026 InvestorPlace Media, LLC